Please use this identifier to cite or link to this item:
Title: Management of metastatic castration-resistant prostate cancer: Insights from urology experts in Thailand
Authors: Lojanapiwat B.
Pripatnanont C.
Choonhaklai V.
Soontornpun S.
Sriplakich S.
Leewansangtong S.
Santi-ngamkun A.
Opanuraks J.
Kongcharoensombat W.
Na-Songkla B.
Raksakul W.
Predanon C.
Issue Date:  1
Abstract: © 2017 Treatment options for castration-resistant prostate cancer (CRPC) are available, but clear instructions for the selection of appropriate treatment are lacking. A meeting of urology experts based in Thailand was convened with the following objectives: (1) to reach a consensus and share real-life experiences about how to identify CRPC; (2) to choose the appropriate treatment for CRPC patients; (3) to evaluate disease progression using novel inhibitors of the androgen receptor pathway; (4) to identify the frequency of monitoring disease; and (5) to promote rational use of corticosteroids in CRPC patients. This consensus document can provide guidance to other urologists in Thailand to provide appropriate treatment to metastatic CRPC patients in a timely manner.
ISSN: 22878882
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.

Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.